Glow Lifetech Corp. (GLOW.CN)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.26 Million CAD | 27.1% |
| 2022 | -1.7 Million CAD | 67.38% |
| 2021 | -4.59 Million CAD | -3310.38% |
| 2020 | -153.47 Thousand CAD | 16.03% |
| 2019 | 740.02 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -180.49 Thousand CAD | 40.77% |
| 2024 Q2 | -167.36 Thousand CAD | 12.66% |
| 2023 Q1 | -252.52 Thousand CAD | 31.93% |
| 2023 FY | - CAD | 27.1% |
| 2023 Q4 | -321.84 Thousand CAD | -6.54% |
| 2023 Q3 | -302.07 Thousand CAD | 8.61% |
| 2023 Q2 | -330.54 Thousand CAD | -30.9% |
| 2022 Q2 | -481.43 Thousand CAD | 20.31% |
| 2022 FY | - CAD | 67.38% |
| 2022 Q1 | -604.1 Thousand CAD | 92.22% |
| 2022 Q4 | -370.99 Thousand CAD | -55.99% |
| 2022 Q3 | -237.83 Thousand CAD | 50.6% |
| 2021 Q4 | -7.76 Million CAD | -1582.6% |
| 2021 FY | - CAD | -3310.38% |
| 2021 Q1 | 4.11 Million CAD | 41204.34% |
| 2021 Q2 | -1.16 Million CAD | -128.36% |
| 2021 Q3 | -461.36 Thousand CAD | 60.45% |
| 2020 FY | - CAD | 16.03% |
| 2020 Q4 | 9958.00 CAD | 111.68% |
| 2020 Q3 | -85.27 Thousand CAD | -119.42% |
| 2020 Q2 | -38.86 Thousand CAD | 1.13% |
| 2020 Q1 | -39.3 Thousand CAD | 20.82% |
| 2019 Q4 | -49.63 Thousand CAD | -40.29% |
| 2019 Q2 | -76.16 Thousand CAD | -252.87% |
| 2019 Q3 | -35.38 Thousand CAD | 53.55% |
| 2019 Q1 | -21.58 Thousand CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -4.98 Million CAD | 74.645% |
| Asep Medical Holdings Inc | -8.13 Million CAD | 84.476% |
| BetterLife Pharma Inc. | -3.19 Million CAD | 60.424% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 83.57% |
| ChitogenX Inc. | -2.69 Million CAD | 53.117% |
| Rapid Dose Therapeutics Corp. | -3.02 Million CAD | 58.243% |
| Defence Therapeutics Inc. | -12.67 Million CAD | 90.036% |
| Entheon Biomedical Corp. | 13.99 Thousand CAD | 9126.235% |
| Gemina Laboratories Ltd. | -5.17 Million CAD | 75.597% |
| Lexston Life Sciences Corp. | -648.32 Thousand CAD | -94.816% |
| Pharmala Biotech Holdings Inc. | -710.18 Thousand CAD | -77.847% |
| Doseology Sciences Inc. | -319.47 Thousand CAD | -295.345% |
| MYND Life Sciences Inc. | -1.82 Million CAD | 30.8% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | -5.052% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 58.499% |
| PreveCeutical Medical Inc. | -955.08 Thousand CAD | -32.243% |
| Telescope Innovations Corp. | -5.49 Million CAD | 76.996% |